Cantor Fitzgerald Reaffirms Ratings for Agios Pharma and Analog Devices

Cantor Fitzgerald has reiterated its 'Overweight' rating for Agios Pharma stock and reaffirmed its rating for Analog Devices stock, citing a positive earnings outlook for the latter.